-
Newcomers South Korea face holders Italy in Davis Cup finals
-
Stocks climb as oil slides, AI buzz returns
-
Japan's Kojima sounds Marchand warning with Asian Games gold
-
India cricketers win in style as Afghan savours 'special' Games silver
-
England rugby star Pollock signs new Northampton deal
-
La Liga president hits out at Real Madrid refereeing 'conspiracy' claims
-
STARTRADER Expands Its Chinese Equity CFD Range with CXMT and Unitree Robotics
-
MEXC Launches “Real Stocks, Real Friends” with Rewards for Bringing Friends to Wall Street
-
MEXC Expands Opportunity Compass with Stock Trading Handbook to Help Crypto Users Build Investment Knowledge
-
Mbappe continues media push for Ballon d'Or recognition
-
England paceman Wood retires from international cricket
-
Stocks rise on AI buzz, oil prices cool
-
Magnificent Mandhana's 79 helps India to Asian Games cricket gold
-
India narrowly survive huge scare against minnows Japan
-
Marchand 'stressed' about racing Japanese rivals at LA Olympics
-
Missing F-35 fighter parts 'not sensitive', says Australia minister
-
Mobile boat clinics bring healthcare to India's remote islands
-
Cambodia showcases scams crackdown with global conference
-
Former India paceman Zaheer Khan named Chennai coach in IPL
-
Afghan cyclist who disguised herself as man wins Asian Games silver
-
Six-year-old Chinese girl sets world record with Rubik's Cube
-
Typhoon Dujuan leaves four dead in Japan, 45,000 houses without power
-
Swimming prodigy Yu, 13, says 'interviews way harder than racing'
-
G7 leaders condemn Houthi strikes on Saudi Arabia
-
Star coaches make their bows as Nations League returns
-
Google data centre sparks protests in Austria
-
Rams bounce back as Giants reel from Dart injury
-
Shin Ohashi: Junk food-loving teen and Japan's next big swimming hope
-
In Bangladesh, Pakistan's Jinnah photo stirs anger
-
Stocks rise on AI buzz, drop in oil prices
-
Two New Zealand naval ships transit Taiwan Strait
-
China's robot dancers limber up for America's Got Talent final
-
Zidane gets down to work as France start new era
-
Despite military might, Saudi struggles to crush the Houthis
-
Inside the Venezuelan prison meant to 'drive you insane'
-
Trump to tout deals, defend Iran war in UN speech
-
UK king braces as memoir by Diana's brother goes on sale
-
Sri Lanka to issue verdict in landmark Easter attack trial
-
No green light to lift EU sanctions on Russian oligarchs, talks to resume
-
Macron says talks with Trump on Red Sea, Ukraine 'constructive'
-
UK agrees support for Saudi in struggle with Houthis: reports
-
Green policies just good politics, says UK minister
-
EU foreign policy chief calls for continued sanctions on Russia
-
Bardot auction in Paris fetches nearly one million euros
-
Flights scrapped, evacuations urged as Typhoon Dujuan wallops Japan
-
No timeline on Daniels injury return, says Commanders coach
-
Fonseca to take break from tennis
-
British Columbia sues OpenAI in US court over Canada school shooting
-
A Cuban zoo, and its animals, in epic battle for survival
-
French star Batum retires after 18-year NBA career
No-prescription birth control pills soon available in US pharmacies
Prescription-free birth control pills will be available across the United States later this month, widening access to contraception at a time when abortion rights have been drastically curtailed.
American-Irish maker Perrigo Company announced Monday that its Opill has "shipped to major retailers and pharmacies and will be available on shelves nationwide," available in one-month and three-month packs for $19.99 and $49.99 respectively. It will also be available on Opill.com.
Over-the-counter (OTC) birth control has long been backed by major medical organizations as a way to reduce barriers to contraception access, with more than 6.1 million births in the US each year unintended, according to official data.
"We champion the right of women and people to determine their own sexual health journey and the availability of Opill over-the-counter is truly a historic moment of which our entire organization can be proud," said Perrigo Executive Vice President Triona Schmelter.
Opill, which was cleared last year by the Food and Drug Administration for sale without prescription, is known as a "mini pill" because it contains progestin only, and works by thickening mucus in the cervix to stop sperm reaching an egg.
Preserving access to contraception has proven politically divisive following the conservative-led Supreme Court's decision to revoke the national right to abortion in 2022.
Twenty-one states banned or moved to restrict abortions to limits tighter than before Roe v Wade, the case law that previously upheld the constitutional right to terminate a pregnancy.
Republicans in Congress also blocked Democrat-backed legislation that would have codified individuals' right to access contraception, an issue that has taken on more urgency as conservative-run states define personhood in new ways.
Alabama's top court last month said that frozen embryos should be considered children, though the state's legislature quickly moved to pass a bill protecting clinics from legal liability if such embryos were inadvertently damaged or destroyed.
Over-the-counter birth control is backed by major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Medical Association and the American Academy of Family Physicians.
Much of Asia, Africa and Latin America allow OTC birth control. The UK joined the club in 2021, but prescriptions are still required in much of mainland Europe including France, Germany, Spain and Italy, according to "Free the Pill" which tracks the issue.
P.Staeheli--VB